AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancer
On May 14, 2020, AIM ImmunoTech announced the FDA authorized the first human trial assessing the safety and…
-
-
Biotechnology | NIH | Oncology | Therapeutics
Roswell Park’s Dr. Pawel Kalinski lead $14.5 million NCI-funded immunotherapy effort
On Apr. 16, 2020, a team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center…
-
AstraZeneca initiated CALAVI clinical trial with Calquence against COVID-19
On Apr. 14, 2020, AstraZeneca initiated a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib)…
-
MediciNova announced plans to initiate a clinical trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome
On Apr. 8, 2020, MediciNova announced that it had initiated a clinical trial of MN-166 (ibudilast) for acute…
-
FDA approved BRAFTOVIﾮ (Encorafenib) in combination with Cetuximab for treatment of BRAFV600E-mutant metastatic colorectal cancer
On Apr. 9, 2020, Pfizer announced that the FDA had approved BRAFTOVIﾮ (encorafenib) in combination with cetuximab (marketed…
-
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
-
The Priestley Medal was awarded to JoAnne Stubbe
On Mar. 23 2020, The Priestley Medal was awarded to JoAnne Stubbe by the American Chemical Society “to…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
-
Gilead acquired Forty Seven for $49 billion in cash
On Mar. 2, 2020, Gilead Sciences announced it had acquired Forty Seven for $95.50 per share in cash…
-
Tim and Mary Boyle gave $10 million to OHSU for joint center for biomedical data science
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
-
The CPRIT awarded 55 new grants totaling over $78 million
On Feb. 19, 2020, the Cancer Prevention & Research Institute of Texas (CPRIT) announced it had awarded 55…
-
New, detailed molecular roadmap boosted fight against endometrial cancer
On Feb. 13, 2020, a study published in Cell provided an unprecedented look at the dozens of molecular…
-
The Pan-cancer analysis of whole genomes was published in Nature
On Feb. 5, 2020, The Pan-cancer analysis of whole genomes was published in Nature. The flagship paper of…
-
International collaboration generated most complete cancer genome map to date
On Feb. 5, 2020, an international team announced that it had completed the most comprehensive study of whole…
-
The Cancer Prevention and Research Institute of Texas announced it had recruited its 200th CPRIT scholar
On Jan. 27, 2020, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had recruited its…
-
Karmanos Cancer Institute was awarded the President’s Trophy for second year in a row by McLaren Health Care
On Jan. 16, 2020, the Barbara Ann Karmanos Cancer Institute received the President’s Trophy for the second year…
-
Thomas J. Lynch Jr became the sixth president of the Fred Hutchinson Cancer Research Center
On Jan. 7, 2020, the Fred Hutchinson Cancer Research Center announced Dr. Thomas J. Lynch Jr. as the…
-
Karmanos Cancer Institute received the 2020 Women’s Choice Award
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…
-
The Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy project
On Dec. 18, 2019, the Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy…
-
FDA granted accelerated approval to Astellas and Seagen PADCEV for people with locally advanced or metastatic urothelial cancer
On Dec. 18, 2019, Seagen and Astellas Pharma announced the U.S. Food and Drug Administration (FDA) had granted…
-
The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grants
On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the recruitment of its…
-
Emory University broke ground on facility to transform cancer care
On Nov. 12, 2019, Emory University Hospital Midtown and Winship Cancer Institute of Emory University (Winship) announced they…
-
Karmanos Cancer Institute established the McLaren Proton Therapy Center
On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…
-
Sanford Burnham Prebys scientists developed a machine-learning algorithm that gleans information from microscope images
On Oct. 22, 2019, scientists at Sanford Burnham Prebys announced they had developed a machine-learning algorithm that gleans…
-
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos, Wayne State received $3.1 million NIH grant to improve quality of life for African American cancer survivors
On Sept. 24, 2019 Karmanos, Wayne State announced it had received a $3.1 million National Institutes of Health…
-
Pascal Biosciences discovered cannabinoids activate the major histocompatibility complex to aid cancer treatment
On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…
-
Scientists at Sanford Burnham Prebys have identified the long-sought structure of an essential blood protein: Vitronectin
On Sept. 11, 2019, scientists at Sanford Burnham Prebys announced they had identified the long-sought structure of an…
-
UCLA researchers used stem cells to engineer cells that attack human tumors in mice
On Sept. 5, 2019, UCLA researchers have harnessed the power of iNKT cells to attack tumor cells and…
-
Siteman Cancer Center received $15 million grant to support personalized leukemia therapies
On Aug. 21, 2019, the Siteman Cancer Center announced it was awarded a $15 million grant to better…
-
Karmanos Cancer Institute became the first in Michigan to offer patients the Leksell Gamma Knife Icon stereotactic radiosurgery system
On Aug. 19, 2019, the Barbara Ann Karmanos Cancer Institute announced it became the first cancer center in…
